Melissa Duimstra
Hospice and Palliative Medicine · Muskegon, MINPI 1578054680
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $479, 3.8 times the $128 reported in 2019. Among hospice and palliative medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $26.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$127
- AstraZeneca$116
- Takeda Pharmaceuticals U.S.A., Inc.$116
- Pfizer$92
- Genentech USA, Inc.$69
- Jazz Pharmaceuticals Inc.$60
- plus $440 from 16 others
What the payments were for
- Food & beverage$1,021100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 5 | $127 |
| AstraZeneca | 2 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Pfizer | 2 | $92 |
| Genentech USA, Inc. | 3 | $69 |
| Jazz Pharmaceuticals Inc. | 2 | $60 |
| Merck | 2 | $60 |
| Eisai Inc. | 2 | $58 |
| Novo Nordisk | 2 | $49 |
| ADC Therapeutics America, Inc. | 1 | $33 |
| Amgen | 2 | $32 |
| Johnson & Johnson | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Genmab U.S., Inc. | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $22 |
| Puma Biotechnology, Inc. | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
How this compares
$1,021 in reported general payments places this provider in the 90th percentile of 58 hospice and palliative medicine providers in Michigan.
See all hospice and palliative medicine providers in Michigan →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $19,039 |
| EliquisApixaban | 18 | $17,622 |
| JardianceEmpagliflozin | 20 | $15,815 |
| Atorvastatin Calcium | 103 | $1,650 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $895 |
| Omeprazole | 54 | $805 |
| Levothyroxine Sodium | 56 | $719 |
| Duloxetine Hcl | 23 | $683 |
| Losartan Potassium | 35 | $573 |
| Lisinopril | 63 | $506 |
| Amlodipine Besylate | 53 | $470 |
| Rosuvastatin Calcium | 22 | $380 |
| Metoprolol Succinate | 19 | $377 |
| Potassium Chloride | 13 | $354 |
| Pravastatin Sodium | 13 | $353 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $92 | $17,62218 claims |
| Boehringer IngelheimJardiance | $14 | $15,81520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 58 hospice and palliative medicine providers in Michigan.
Other hospice and palliative medicine in Muskegon
- Gerald HarrimanMuskegon$1K
- Terry GardinerMuskegon$127
- Ryan StringerGrand Rapids$4K
- Gretchen RoeGrand Rapids$2K
- Lameitre LockhartSouthfield$1K
- Mark StidHolland$1K
- Simin BegGrand Rapids$847
- David SchwartzenfeldRochester Hills$826
- Zohra KhanBloomfield Hills$495
- Jaya GuptaDetroit$459
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.